Skip to main content
Clinical Trials/NCT04148274
NCT04148274WithdrawnNot Applicable

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis

ProgenaBiome1 site in 1 country100 target enrollmentStarted: March 2, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing

Study Overview

Brief Summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Ulcerative Colitis

Detailed Description

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding Ulcerative Colitis

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
  • Male or female patients of any age.
  • Diagnosis of Ulcerative Colitis

Exclusion Criteria

  • Refusal to sign informed consent form
  • History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
  • Postoperative stoma, ostomy, or ileoanal pouch
  • Participation in any experimental drug protocol within the past 12 weeks
  • Treatment with total parenteral nutrition
  • Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
  • Inability to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

Outcomes

Primary Outcomes

Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing

Time Frame: One year

Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among specific gastrointestinal disease types.

Secondary Outcomes

  • Validation of Sequencing Methods(One year)

Investigators

Sponsor
ProgenaBiome
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials